Gilead’s new hepatitis C treatment Sovaldi®

Sovaldi (sofosbuvir) should be made available, as part of a combination treatment regimen, to treat the majority of adult patients with chronic hepatitis C in England and Wales.
Source: Pharmacy Europe - Category: Drugs & Pharmacology Authors: Tags: *** Editor's Pick Hepatic disorders chronic hepatitis C gilead hcv Latest News National Institute for Health and Care Excellence nice Sofosbuvir Sovaldi Source Type: news